Dow Rises 0.3% While Tesla and Meta Cap Nasdaq Gains

We think the S&P 500 finishes Wednesday up 0.15% while the Dow Jones Industrial Average leads with a 0.28% advance. The Nasdaq 100 sits on a five-day decline of 3.53%, and after missing directional calls by leaning into tech rallies too early, we are keeping our technology index forecast anchored at a neutral 0.10% gain. Regular trading will be driven by morning cash generators in healthcare and industrials, while options traders keep major tech bellwethers restrained ahead of evening numbers.

The morning session belongs to stable balance sheets. Abbott Laboratories (ABT) reports third-quarter numbers before the bell with consensus expecting earnings of 1.20 dollars per share on 10.7 billion dollars in revenue. Hospital surgical volumes have remained steady, and Abbott Laboratories (ABT) converts continuous glucose monitor sales into predictable mid-single-digit expansion. Danaher (DHR) also reports pre-market, where bioprocessing equipment order cancellations have ceased. Together with AT&T (T), which is projected to generate over 4.0 billion dollars in quarterly free cash flow, these dividend payers give money managers a reason to buy defensive shares early in the day.

Technology hardware and internet platforms face a different test after the 4:00 PM close. Meta Platforms (META) trades near its 20-day moving average, with investors laser-focused on whether full-year capital expenditure plans push beyond 40 billion dollars. While digital advertising pricing remains solid, institutional buyers are reluctant to bid the stock up during regular hours without confirmation that artificial intelligence infrastructure investments are expanding operating margins. Similarly, Tesla (TSLA) options price an expected post-earnings move of 6.5%, keeping regular-session volume quiet as traders await automotive gross margins excluding regulatory credits, where consensus sits at 15.0%.

In enterprise IT, cash discipline provides support. International Business Machines (IBM) reports after the close, carrying 5.5% annual revenue growth in Red Hat software and an expanding enterprise generative AI book of business that exceeded 2 billion dollars last quarter. International Business Machines (IBM) has beaten earnings consensus in seven of its last eight quarters, offering a lower-volatility software anchor while semiconductor suppliers like Texas Instruments (TXN) work through slower analog chip orders from industrial factory builders.

On the interest rate side, the 10-Year US Treasury yield sits flat near 4.10% with no top-tier central bank announcements scheduled. Without a yield spike forcing multiple contraction, broad equity valuation multiples can hold their ground. We expect the Industrial Select Sector SPDR Fund (XLI) to advance 0.3% and Healthcare to rise 0.4%, pulling the broader market into a modest green close.

A clear failure of our thesis would look like this: Abbott Laboratories (ABT) or Elevance Health (ELV) issuing steep guidance cuts that push healthcare down more than 1.5%, or the 10-Year Treasury yield breaking above 4.16% on unexpected bond auction concessions. Barring those catalysts, cash-generating blue chips will keep the S&P 500 slightly positive into the closing bell.